{"Symbol": "ARCT", "AssetType": "Common Stock", "Name": "Arcturus Therapeutics Holdings Inc", "Description": "Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases. The company is headquartered in San Diego, California.", "CIK": "1768224", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA, UNITED STATES, 92121", "OfficialSite": "https://arcturusrx.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "204867000", "EBITDA": "-75185000", "PERatio": "None", "PEGRatio": "None", "BookValue": "8.24", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-2.46", "RevenuePerShareTTM": "3.598", "ProfitMargin": "-0.683", "OperatingMarginTTM": "-0.963", "ReturnOnAssetsTTM": "-0.15", "ReturnOnEquityTTM": "-0.274", "RevenueTTM": "97601000", "GrossProfitTTM": "-94394000", "DilutedEPSTTM": "-2.46", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "-0.588", "AnalystTargetPrice": "33.56", "AnalystRatingStrongBuy": "2", "AnalystRatingBuy": "6", "AnalystRatingHold": "3", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "2.478", "PriceToSalesRatioTTM": "2.099", "PriceToBookRatio": "0.912", "EVToRevenue": "0.593", "EVToEBITDA": "-25.67", "Beta": "2.429", "52WeekHigh": "24.17", "52WeekLow": "5.85", "50DayMovingAverage": "7.07", "200DayMovingAverage": "12.28", "SharesOutstanding": "28414300", "SharesFloat": "26273400", "PercentInsiders": "7.540", "PercentInstitutions": "82.770", "DividendDate": "2017-11-16", "ExDividendDate": "None"}